Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06544954 · ClinicalTrials.gov registry record · NA
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
A NA study of Inflammation and Blood Pressure, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06544954 is a NA study of Inflammation and Blood Pressure that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06544954, a NA study of Inflammation and Blood Pressure, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess the impact of table grape consumption on gut microbiome, intestinal permeability, systemic inflammation, and vascular function in healthy overweight men and women aged 45-70 years. The main questions it aims to answer are: * Does daily grape intake alter intestinal microbiome composition and intestinal permeability? * Are changes in gut microbiota and intestinal permeability correlated with changes in cardiometabolic risk factors (inflammation, vascular function, lipid profiles)? * Does response to grape intake on gut microbiota, intestinal permeability, cardiometabolic and inflammatory markers differ between men and women? * Are metabolic pathways modified by grape consumption able to explain the link between gut health and cardiometabolic factors? Researchers will compare freeze-dried grape powder to placebo powder to see if grape powder improves cardiometabolic risk factors. Participants will * Consume the powder dissolved in water twice daily for 3 weeks * Follow their usual diet, modified to limit polyphenol-rich foods * Visit the clinic at the beginning and end of the intervention for vascular measurements and blood sample collection * Complete a 3-day 24-hour dietary recall and collect stool sample before each visit
Conditions Studied
Interventions
- OTHER Placebo powder
- DIETARY_SUPPLEMENT Freeze-dried grape powder
Study Locations (1)
California
- Ragle Human Nutrition Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-12-02 |
| Est. Completion | 2026-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06544954
The ClinicalTrials.gov registry entry for NCT06544954 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (86% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo powder is the first listed.
NCT06544954 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06544954 about?
NCT06544954 is a clinical study titled "Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women". The goal of this clinical trial is to assess the impact of table grape consumption on gut microbiome, intestinal permeability, systemic inflammation, and vascular function in healthy overweight men and women aged 45-70 years. The main questions it aims to answer are: * Does daily grape intake alter...
What is the current status of trial NCT06544954?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-12-02. Estimated completion is 2026-01.
What conditions does trial NCT06544954 study?
This clinical trial studies the following conditions: Inflammation, Blood Pressure, Dysbiosis, Arterial Stiffness, Permeability; Increased.
What interventions are being tested in trial NCT06544954?
The interventions under investigation include: Placebo powder (OTHER), Freeze-dried grape powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06544954?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06544954 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.